+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 50Years - 80Years
All Genders
Healthy Volunteers
ID07324330

Study to Slow Cognitive Decline in Parkinsons and Related Diseases by Increasing Physical Activity Using a Smartphone App in Adults Aged 50 to 80

Led by University Hospital, Bonn · Updated on 2026-01-16

130

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Alpha-synucleinopathies, including Parkinsons disease and dementia with Lewy bodies, are common neurodegenerative diseases characterized by motor decline and cognitive impairment. Isolated REM sleep behavior disorder iRBD is an early sign of these diseases before significant motor or cognitive symptoms appear. This research aims to study whether increasing physical activity in daily life can help preserve cognitive functions in individuals with iRBD, using a randomized, double-blind, actively controlled trial design conducted over one year. Participants will use a motivational smartphone application called Alpha-Fit to increase their physical activity based on their baseline levels. The study compares two groups with different activity goals one aiming to double their baseline step count and moderate to vigorous physical activity, and the other aiming for a smaller increase of about 10%. The intervention lasts 12 months, with the app providing feedback and support to encourage reaching individual goals. During the study, participants undergo neuropsychological tests to assess cognitive performance as the primary outcome. Secondary assessments include motor function tests, sleep quality evaluation through polysomnography, blood markers related to metabolism, neurodegeneration, and inflammation, as well as brain imaging by MRI. The study recruits 80 individuals with iRBD and 50 healthy controls aged 50 to 80 years. Participants progress and safety are monitored throughout the 12 months, including adherence to physical activity goals and any changes in clinical or biological markers.

CONDITIONS

Brief Title

Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity

Research Team

M

Martin M Rodemann

E

Emily L Fitzgibbon, M.Sc.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here